The Biden administration designated fentanyl-xylazine combinations as an “emerging threat” April 12.
Read the full post on Becker's Hospital Review - Healthcare News
The Biden administration designated fentanyl-xylazine combinations as an “emerging threat” April 12.
Read the full post on Becker's Hospital Review - Healthcare News